Table 2. OCPeD, Depressive PeD and clinical characteristics.
OCDeP | Depressive PeD | |||||||
N (%) | OR | 95%CI | p-value | N (%) | OR | 95%CI | p-value | |
Age | ||||||||
≤60 | 11 (22.9) | 1 | 10 (20.8) | 1 | ||||
>60 | 29 (55. 8) | 4.24 | 1.78–10.1 | 0.001 | 4 (7.7) | 0.31 | 0.09–1.08 | 0.07 |
Early onset | ||||||||
≤40 | 2 (16.7) | 1 | 2 (16.7) | 1 | ||||
>40 | 38 (43.2) | 3.8 | 0.79–18.4 | 0.1 | 12 (13.6) | 0.79 | 0.15–4.05 | 0.8 |
sex | ||||||||
Women | 14 (32.6) | 1 | 10 (23.3) | 1 | ||||
Men | 26 (45.6) | 1.73 | 0.76–3.96 | 0.2 | 4 (7.0) | 0.24 | 0.07–0.85 | 0.02 |
UPDRS-ME | ||||||||
≤23 | 21 (38.9) | 1 | 5 (9.3) | 1 | ||||
>23 | 19 (41.3) | 1.10 | 0.49–2.47 | 0.8 | 9 (19.6) | 2.38 | 0.73–7.71 | 0.1 |
Treatment | ||||||||
None | 8 (50.0) | 1 | 2 (12.5) | 1 | ||||
LD | 20 (37.7) | 0.60 | 0.20–1.87 | 0.3 | 7 (13.2) | 1.06 | 0.20–5.72 | 0.07 |
DA | 1 (14.3) | 0.16 | 0.02–1.72 | 0.1 | 2 (28.6) | 2.8 | 0.31–25.52 | 0.9 |
LD +DA | 9 (47.4) | 0.9 | 0.24–3.41 | 0.9 | 3 (15.8) | 1.31 | 0.19–9.02 | 0.3 |
others | 2 (40.0) | 0.67 | 0.09–5.13 | 0.7 | 0 (0) | / | / | / |
LD = Levodopa; DA = Dopamine Agonist;